학술논문

Soluble Guanylate Cyclase α1–Deficient Mice: A Novel Murine Model for Primary Open Angle Glaucoma
Document Type
Journal Article
Source
Buys, Emmanuel, Yu-Chieh Ko, Clemens Alt, Sarah R. Hayton, Alexander Jones, Laurel T. Tainsh, Ruiyi Ren, et al. 2013. Soluble guanylate cyclase α1–deficient mice: A novel murine model for primary open angle glaucoma. PLoS ONE 8(3): e60156.
Subject
Biology
Genetics
Human Genetics
Genetic Association Studies
Model Organisms
Animal Models
Mouse
Molecular Cell Biology
Signal Transduction
Signaling in Cellular Processes
cGMP signaling
Medicine
Cardiovascular
Peripheral Vascular Diseases
Clinical Research Design
Animal Models of Disease
Ophthalmology
Glaucoma
Retinal Disorders
Language
English
ISSN
1932-6203
Abstract
Primary open angle glaucoma (POAG) is a leading cause of blindness worldwide. The molecular signaling involved in the pathogenesis of POAG remains unknown. Here, we report that mice lacking the \(α_1\) subunit of the nitric oxide receptor soluble guanylate cyclase represent a novel and translatable animal model of POAG, characterized by thinning of the retinal nerve fiber layer and loss of optic nerve axons in the context of an open iridocorneal angle. The optic neuropathy associated with soluble guanylate cyclase \(α_1\)–deficiency was accompanied by modestly increased intraocular pressure and retinal vascular dysfunction. Moreover, data from a candidate gene association study suggests that a variant in the locus containing the genes encoding for the \(α_1\) and \(β_1\) subunits of soluble guanylate cyclase is associated with POAG in patients presenting with initial paracentral vision loss, a disease subtype thought to be associated with vascular dysregulation. These findings provide new insights into the pathogenesis and genetics of POAG and suggest new therapeutic strategies for POAG.